Protective effect of DNA immunization against mycobacterial infection is associated with the early emergence of interferon‐gamma (IFN‐γ)‐secreting lymphocytes
暂无分享,去创建一个
A. Bean | W. Britton | A. Kamath | A G Bean | W J Britton | A T Kamath | N L Groat | N. L. Groat
[1] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.
[2] P. D. Hart,et al. The immunity conferred by effective BCG and vole bacillus vaccines, in relation to individual variations in induced tuberculin sensitivity and to technical variations in the vaccines , 1967 .
[3] Malin,et al. Human cytolytic and interferon g-secreting CD 8 1 T lymphocytes specific for Mycobacterium tuberculosis , 1997 .
[4] M. Horwitz,et al. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[5] H. Macdonald,et al. The cellular basis of T-cell memory. , 1989, Annual review of immunology.
[6] P. Andersen,et al. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins , 1994, Infection and immunity.
[7] W. Britton,et al. Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis. , 1999, Infection and immunity.
[8] C. Fathman,et al. A subset of memory CD4+ helper T lymphocytes identified by expression of Pgp-1 , 1989, The Journal of experimental medicine.
[9] Christopher Dye,et al. Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country , 1999 .
[10] T. Springer,et al. Human memory T lymphocytes express increased levels of three cell adhesion molecules (LFA-3, CD2, and LFA-1) and three other molecules (UCHL1, CDw29, and Pgp-1) and have enhanced IFN-gamma production. , 1988, Journal of immunology.
[11] M. Colston,et al. Protection Against Tuberculosis by Plasmid DNA , 1997 .
[12] S. Furney,et al. Characteristics of protective immunity engendered by vaccination of mice with purified culture filtrate protein antigens of Mycobacterium tuberculosis. , 1995, Immunology.
[13] A. L. Sørensen,et al. Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice. , 1995, Journal of immunology.
[14] Niang,et al. T-cell-epitope mapping of the major secreted mycobacterial antigen Ag85A in tuberculosis and leprosy , 1994, Infection and immunity.
[15] David Gray,et al. Immunological Memory and Protective Immunity: Understanding Their Relation , 1996, Science.
[16] R. Coler,et al. Molecular characterization and human T-cell responses to a member of a novel Mycobacterium tuberculosis mtb39 gene family. , 1999, Infection and immunity.
[17] M. Singh,et al. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors. , 1999, Journal of immunology.
[18] B. Gicquel,et al. Persistence and Protective Efficacy of aMycobacterium tuberculosis Auxotroph Vaccine , 1999, Infection and Immunity.
[19] S. Kaufmann,et al. Protective role of γ/δ T cells and α/β T cells in tuberculosis , 1995 .
[20] H. Vordermeier,et al. Functions and specificity of T cells following nucleic acid vaccination of mice against Mycobacterium tuberculosis infection. , 1997, Journal of immunology.
[21] Paul C. Rogers,et al. From Naive to Memory T Cells , 1996, Immunological reviews.
[22] C. Palmer,et al. Long-term results of BCG vaccination in the southern United States. , 1966, The American review of respiratory disease.
[23] H. Dockrell,et al. Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[24] I. Orme,et al. Disseminated tuberculosis in interferon gamma gene-disrupted mice , 1993, The Journal of experimental medicine.
[25] M. Colston,et al. Vaccination against tuberculosis by DNA injection , 1996, Nature Medicine.
[26] H. Macdonald,et al. Distinction of virgin and memory T lymphocytes. Stable acquisition of the Pgp-1 glycoprotein concomitant with antigenic stimulation. , 1987, Journal of immunology.
[27] A. McMichael,et al. Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime/MVA boost vaccination regime. , 1998, Vaccine.
[28] S. Reed,et al. Characterization of Human CD8+ T Cells Reactive with Mycobacterium tuberculosis–infected Antigen-presenting Cells , 1998, The Journal of experimental medicine.
[29] P. Gounon,et al. Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene. , 1998, Science.
[30] G. Colditz,et al. Relationship between bacille Calmette-Guérin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[31] I. Orme,et al. T cell response to Mycobacterium tuberculosis. , 1993, The Journal of infectious diseases.
[32] I. Orme,et al. Evolution of CD4 T-cell subsets following infection of naive and memory immune mice with Mycobacterium tuberculosis , 1994, Infection and immunity.
[33] H. Billman-Jacobe,et al. T-cell determinants and antibody binding sites on the major mycobacterial secretory protein MPB59 of Mycobacterium bovis , 1994, Infection and immunity.
[34] Donna L. Montgomery,et al. Immunogenicity and protective efficacy of a tuberculosis DNA vaccine , 1996, Nature Medicine.
[35] Marion Becker,et al. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara , 1998, Nature Medicine.
[36] K. Lukacs,et al. Protection against Mycobacterium tuberculosisInfection by CD8+ T Cells Requires the Production of Gamma Interferon , 1998, Infection and Immunity.
[37] C. Dye,et al. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.
[38] I. Orme,et al. Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[39] W. Britton,et al. Immunogenicity and protection studies with recombinant mycobacteria and vaccinia vectors coexpressing the 18-kilodalton protein of Mycobacterium leprae , 1996, Infection and immunity.
[40] S. Kaufmann,et al. Gamma interferon and interleukin 2, but not interleukin 4, are detectable in gamma/delta T-cell cultures after activation with bacteria , 1992, Infection and immunity.
[41] C S Berkey,et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. , 1994, JAMA.
[42] G. Kronvall,et al. Immunoglobulin-binding structure on bovine group G streptococci different from type III Fc receptors on human group G streptococci , 1979, Infection and immunity.
[43] C. L. Silva,et al. Protection against tuberculosis by a plasmid DNA vaccine. , 1997, Vaccine.
[44] A. Bean,et al. Increase in Gamma Interferon-Secreting CD8+, as Well as CD4+, T Cells in Lungs following Aerosol Infection with Mycobacterium tuberculosis , 1999, Infection and Immunity.
[45] E. Engleman,et al. CTL response to Mycobacterium tuberculosis: identification of an immunogenic epitope in the 19-kDa lipoprotein. , 1998, Journal of immunology.